Bethânia Rosa Lorençone, Lucas Pires Guarnier, Rhanany Alan Calloi Palozi, Paulo Vitor Moreira Romão, Aline Aparecida Macedo Marques, Lislaine Maria Klider, Roosevelt Isaias Carvalho Souza, Ariany Carvalho Dos Santos, Cleide Adriane Signor Tirloni, Nadla Soares Cassemiro and 3 more
Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 7 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 3 institutions in 1 country.
Bethânia Rosa LorençoneLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.ORCID 0000-0002-6573-7535
Lucas Pires GuarnierLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.ORCID 0000-0002-0733-1975
Rhanany Alan Calloi PaloziLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.ORCID 0000-0002-8941-6592
Paulo Vitor Moreira RomãoLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.
Aline Aparecida Macedo MarquesLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.
Lislaine Maria KliderPostgraduate Program in Pharmaceutical Sciences, State University of Ponta Grossa, Ponta Grossa 84.030-900, PR, Brazil.
Roosevelt Isaias Carvalho SouzaLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.
Ariany Carvalho Dos SantosLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.
Cleide Adriane Signor TirloniLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.
Nadla Soares CassemiroLaboratory of Natural Products and Mass Spectrometry (LaPNEM), Faculty of Pharmaceutical Sciences, Food and Nutrition (FACFAN), Federal University of Mato Grosso do Sul, Campo Grande 79.070-900, MS, Brazil.
Denise Brentan SilvaLaboratory of Natural Products and Mass Spectrometry (LaPNEM), Faculty of Pharmaceutical Sciences, Food and Nutrition (FACFAN), Federal University of Mato Grosso do Sul, Campo Grande 79.070-900, MS, Brazil.ORCID 0000-0003-0872-2756
Jane Manfron BudelPostgraduate Program in Pharmaceutical Sciences, State University of Ponta Grossa, Ponta Grossa 84.030-900, PR, Brazil.ORCID 0000-0003-1873-2253
Arquimedes Gasparotto JuniorLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79.804-970, MS, Brazil.ORCID 0000-0003-3433-5098
Universidade Federal da Grande Dourados · BRUniversidade Estadual de Ponta Grossa · BRUniversidade Federal de Mato Grosso do Sul · BR
Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico no. 449464/2014-8 and 407685/2018-9Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul no. 59/300.046/2015 and 71/700.135/2018
6 · The paper itself
Abstract
background
methodsFirst, an anatomical study of the
resultsProlonged treatment with ESCS induces significant hypolipidemic and antioxidant effects, that prevent endothelial dysfunction and modulated the local inflammatory process, reducing the evolution of the atherosclerotic disease.
conclusionsThis study provides a scientific basis for the popular use of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Atheroprotective Properties of · full record | OpenQuestion